Summary#

SR-118, “Relative to Prostate Cancer Awareness Month,” is a California Senate resolution, not a law that creates a new screening program or changes existing requirements. It designates September 2026 as Prostate Cancer Awareness Month; its stated goal is to raise awareness and encourage informed conversations about screening and early detection.

• The Senate encourages people, especially those at higher risk, to discuss screening with their health care providers.
• The Senate urges greater awareness of continued vigilance in prostate cancer testing.
• The Secretary of the Senate must send copies of the resolution to its author for distribution.

What it means for you#

• Individuals: You are encouraged—not required—to discuss your personal risk and screening with a health care provider.
• Patients and health care providers: The resolution does not require screening, set testing rules, or change medical guidance.
• General public: The resolution designates September 2026 as an awareness month. It does not create a new service, benefit, or funding program.

Money#

No publicly available information on cost.

• The resolution does not state a spending amount or create funding for awareness activities.

What is unclear#

• The resolution does not specify what “increased awareness” or “continued vigilance” would involve.
• It does not set out who would lead awareness activities, beyond requiring the Secretary of the Senate to send copies to the author for distribution.
• It does not explain how its encouragement relates to specific screening guidance or how patients should weigh screening’s benefits and risks.

Case for#

• The resolution identifies prostate cancer risks and says early cancer may have no noticeable symptoms.
• It encourages people to discuss their own risk and the benefits and risks of screening with a health care provider, rather than requiring everyone to be tested.
• A possible argument for the resolution is that a designated awareness month can draw attention to those discussions and to early detection.

Case against#

• One concern is that the resolution urges awareness but does not fund or organize specific activities to achieve it.
• It stresses continued vigilance in testing but does not explain what that means alongside its recognition that screening has both benefits and risks.
• The resolution does not establish how anyone would assess whether awareness or screening discussions increase.